Development and full validation of a sensitive quantitative assay for the determination of clemastine in human plasma by liquid chromatography–tandem mass spectrometry

Add time:09/04/2019    Source:sciencedirect.com

A sensitive high-performance liquid chromatography–tandem mass spectrometry (LC/MS/MS) method was developed and validated for the determination of clemastine in human plasma. After having been extracted from plasma samples by ethyl acetate, clemastine and internal standard, diphenhydramine, were separated on a C18 column. Detection was performed on Thermo Finnigan TSQ Quantum triple quadrupole mass spectrometer by selected reaction monitoring (SRM) mode via electrospray ionization (ESI) source. The method was linear in the concentration range of 5.0–1000.0 pg/ml for clemastine. The intra- and inter-day precisions were within 13.4% and the deviations were between −1.1% and 5.6%. The fully validated LC/ESI-MS/MS method has been successfully applied to the preliminary pharmacokinetic study in healthy male Chinese volunteers.

We also recommend Trading Suppliers and Manufacturers of CLEMASTINE FUMARATE (cas 15686-51-8). Pls Click Website Link as below: cas 15686-51-8 suppliers

Prev:Short communicationDetermination of clemastine in human plasma by gas chromatography with nitrogen–phosphorus detection
Next:High-performance liquid chromatographic-tandem mass spectrometric method for the determination of clemastine in human plasma)